Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PABGXT. Rowe Price Blue Chip Growth Fund Advisor Class | $199.96 | +2.23% | $100.3B | — |
| AMCPXAmerican Funds AMCAP A | $44.79 | +1.52% | $98.6B | — |
| CAIBXAmerican Funds Capital Income Builder Class A | $82.02 | +0.42% | $128.5B | — |
| PRUFXT. Rowe Price Growth Stock Fund I Class | $110.26 | +2.19% | $87.1B | — |
| RAFFXAmerican Funds AMCAP R5 |
No one on the platform currently holds PABGX.
No tracked institution reports a position in PABGX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-11 | $11.0323 | 2025-12-12 |
| 2024-12-12 | $16.4232 | 2024-12-13 |
| 2023-12-13 | $5.2095 | 2023-12-14 |
No one on the platform has traded PABGX yet.
| $46.44 |
| +1.53% |
| $98.6B |
| — |
| RIRGXAmerican Funds Capital Income Builder | $81.98 | +0.43% | $128.5B | — |
| RRBGXT. Rowe Price Blue Chip Growth Fund Class R | $185.03 | +2.23% | $92.8B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.